Lucile Packard Children’s Hospital Stanford Transplant Program Among Nation’s Elite, #1 on West Coast

* Statistics highlight preeminence of liver, kidney, heart and lung programs

For Release: April 15, 2014

STANFORD, Calif. – In new data from the Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network, the transplant center at Lucile Packard Children’s Hospital Stanford is once again confirmed as a regional and national leader in solid organ transplants.

The organizations, both of which support ongoing evaluation of the status of solid organ transplantation in the United States, noted the following achievements:

• No. 1 in the volume of liver transplants on the West Coast and No. 2 in the United States, with a 100 percent patient survival rate at one and three years post-transplantation. Additionally, SRTR data reflect the liver transplant program is the only one in the country to have graft and patient survival rates that are statistically significant, and represent higher-than-expected outcomes.
• No. 1 in the volume of kidney transplants on the West Coast and No. 2 in the United States, with a 100 percent patient survival rate at one and three years post-transplantation.
• No. 1 in heart transplant volume (tie) on the West Coast and No. 3 in the United States, with a 90 percent patient survival rate at one year post-transplantation and an 88.8 percent patient survival rate at three years post-transplantation, compared to an 83.5 percent national average three years post-transplantation.
• No. 1 in lung transplant volume on the West Coast, with a 100 percent patient survival rate one year post-transplantation.

Together, these services rank No. 2 in transplant volume overall in the United States (after Texas Children’s Hospital).

“These reports speak to our phenomenal experience,” said Carlos Esquivel, MD, PhD, “and experience saves lives.” Esquivel, who is the Arnold and Barbara Silverman Professor of Surgery and chief of abdominal transplantation at the Stanford School of Medicine, noted the SRTR and OPTN data prove that, “Stanford’s clinical and research programs are among the nation’s elite, and we continue to be international leaders in the development of transplant protocols.”

Stanford’s history of innovation in transplant is deep, including the advancement of a broad range of options and techniques to increase the donor pool, thus minimizing wait times and providing children with a better chance for a healthy life. “We are very proud of having shorter median wait times for transplant than the United States average,” added Esquivel, who is celebrating his 30th anniversary as a transplant surgeon.

The transplant program at Lucile Packard Children’s Hospital Stanford is also a leader in multi-organ transplant success. For instance, the liver transplant program offers liver-kidney, liver-heart, liver-lung and liver-intestine transplants, and utilizes full-size liver donors, split-liver, reduced-size liver and living donors.

“These transplant teams represent the best in transplant innovation,” said Kenneth Cox, MD, chief medical officer at Stanford Medicine Children’s Health and professor of pediatrics at the Stanford School of Medicine. “Each is a leader in world-class care and extraordinary outcomes, and our patient families are very grateful.”

Authors

Contact:
Robert Dicks
(650) 497-8364
rdicks@stanfordchildrens.org